🔎 Trials Near Me

Home › Prostate Cancer › Wisconsin › Sheboygan

Prostate Cancer clinical trials in Sheboygan, WI

4 studies for Prostate Cancer are looking for participants at sites in and around Sheboygan (within about 30 miles). Open a study to see who can join and how to contact the study team.

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RecruitingPhase 2
  • Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

RecruitingPhase 3
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan
  • Sheboygan Physicians Group, Sheboygan
  • Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

RecruitingPhase 3
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan
  • Sheboygan Physicians Group, Sheboygan
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT06931340

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan
  • Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069

About Prostate Cancer

Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.

More about Prostate Cancer on MedlinePlus

Prostate Cancer trials in other cities

Other studies in Sheboygan

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.